Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Grab Holdings Ltd. (GRAB) vs Revvity Inc (RVTY) Price & Performance

Grab Holdings Ltd.Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Grab Holdings Ltd. vs Revvity Inc — how do they compare? Grab Holdings Ltd. trades at $3.72 (market cap $15.62B), while Revvity Inc trades at $111.36 (market cap $12.42B). The key difference: Grab Holdings Ltd. is the larger of the two by market cap, and Revvity Inc pays a 0.25% dividend while Grab Holdings Ltd. pays none. Which is the better fit depends on your goals.

GRABRVTY
Market Cap
$15.62B$12.42B
Sector
TechnologyTechnology
52-Week High
$6.45$117.75
52-Week Low
$3.27$82.26
Enterprise Value
$11.32B$14.91B
Dividend Yield
0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Grab Holdings Ltd.

GRAB trades at $3.715, down 2.24% today, with a bullish technical signal from moving averages. The company achieved profitability in 2025 with $268M net income and 7.95% margin, showing significant improvement from previous losses. Revenue grew to $3.37B in 2025, with strong analyst consensus of 11 buys versus 1 sell. Recent news includes CEO share sales and Uber CEO's board departure, creating some investor uncertainty despite positive earnings beats.

GRAB presents a compelling turnaround story with recent profitability and strong growth prospects in Southeast Asian markets. The stock trades at a discount to the $5.45 consensus target, offering 47% upside potential. Key risks include competitive pressures, execution challenges in expanding financial services, and insider selling activity. The company's improving cash flow and debt management support the bullish analyst outlook.

Revvity Inc

RVTY trades at $110.99, down slightly by 0.2% today, near the analyst consensus price target of $111.43. The stock shows a bullish technical trend with recent earnings beats in Q3 2025, Q4 2025, and Q1 2026. Strong profitability metrics include a gross margin of 54.32% and net income margin of 8.26%. Recent news highlights AI integration advancements and FDA clearances, supporting growth prospects.

The outlook is positive with analyst consensus leaning buy (51.72%) and no sell ratings. Key risks include margin pressure and macroeconomic headwinds affecting cash flow, which turned negative in 2025 and 2026. The upcoming Q2 2026 earnings report on August 4, 2026, will be critical for validating current growth trajectory and investor confidence.

Returns comparison

Trailing returns across standard periods

About Grab Holdings Ltd.

Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.

Read more on GRAB

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY